Prognostic score models for acquired resistance to frontline anti-programmed cell death protein 1/programmed death-ligand 1 therapy in metastatic non-small-cell lung cancer by J.C. Murray, Q. Huang, Y.-C. Chen, C. Hu, R.L. DiSantostefano, C. Wong, L. Glatz, E. Curran, L.C. Villaruz, A.N. Hasan, A.J. Schoenfeld

Get full text